Finance

Beta
Lists
TEM:NASDAQ
Tempus AI Inc
$54.87
+5.64%
(+2.93) 1D
$54.34
-0.97% (-0.53)
Pre-market
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TEM...
Open
$52.59
High
$55.65
Low
$52.57
Mkt. cap
9.85B
Avg. vol.
6.77M
Volume
101.98K
52-wk high
$104.32
52-wk low
$41.73
EPS
-$1.71
Shares outstanding
174.52M
No. of employees
4K
Open
$52.59
High
$55.65
Low
$52.57
Mkt. cap
9.85B
Avg. vol.
6.77M
Volume
101.98K
52-wk high
$104.32
52-wk low
$41.73
EPS
-$1.71
Shares outstanding
174.52M
No. of employees
4K
News stories
From sources across the web
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com
Analyst ratings
Based on 16 analysts giving stock ratings to TEM in the past 3 months
Buy
Buy
9
Hold
6
Sell
1
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TEM in the last 3 months.
Highest
Current $54.87
$100.00 (+82.25%)
Average
$65.93 (+20.16%)
Lowest
$35.00 (-36.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$80.00
+45.8%
06/02/2026
Paige Chamberlain‏
Wolfe Research
Hold
Initiated
-
-
06/01/2026
Unknown Analyst
Wolfe Research
Hold
Initiated
-
-
06/01/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
$60.00
+9.3%
06/01/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$60.00
+9.3%
06/01/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$68.00
+23.9%
06/01/2026
Mark Massaro
BTIG
Buy
Reiterated
$80.00
+45.8%
06/01/2026
Ryan MacDonald
Needham
Buy
Reiterated
$75.00
+36.7%
06/01/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
$64.00
+16.6%
06/01/2026
Andrew Brackmann
William Blair
Hold
Reiterated
-
-
06/01/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
$50.00
-8.9%
06/01/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
$70.00
+27.6%
05/12/2026
David Westenberg
Piper Sandler
Hold
Maintained
$58.00
+5.7%
05/12/2026
Yi Chen
H.C. Wainwright
Buy
Maintained
$64.00
+16.6%
05/11/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$59.00
+7.5%
05/06/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$100.00
+82.2%
04/13/2026
Tycho Peterson
Jefferies
Sell
Initiated
$35.00
-36.2%
04/12/2026
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.13 / -$0.20
+35.35%beat
Revenue / Est. (USD)
348.12M / 345.44M
+0.78%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
314.64M
334.21M
367.21M
348.12M
Cost of goods sold
119.60M
124.26M
129.50M
126.08M
Cost of revenue
119.60M
124.26M
129.50M
126.08M
Research and development expenses
76.10M
83.05M
90.62M
94.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
179.21M
187.39M
208.41M
212.60M
Operating expense
255.31M
270.44M
299.03M
306.76M
Total operating expenses
374.91M
394.70M
428.52M
432.83M
Operating income
-60.27M
-60.50M
-61.31M
-84.72M
Other non operating income
3.92M
3.88M
2.83M
4.60M
EBT including unusual items
-42.63M
-79.71M
-60.16M
-125.98M
EBT excluding unusual items
-78.94M
-65.90M
-71.80M
-93.68M
Income tax expense
212.00K
276.00K
-5.99M
-62.00K
Effective tax rate
-0.50%
-0.35%
9.96%
0.05%
Other operating expenses
-
-
-
-
Net income
-42.84M
-79.98M
-54.17M
-125.92M
Net profit margin
-13.62%
-23.93%
-14.75%
-36.17%
Earnings per share
-0.22
-0.11
-0.04
-0.13
Interest and investment income
1.09M
4.60M
5.12M
3.87M
Interest expense
-21.58M
-15.40M
-15.29M
-14.34M
Net interest expenses
-20.49M
-10.80M
-10.16M
-10.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.28M
-40.69M
-41.71M
-58.54M
Gain or loss from assets sale
-
-
415.00K
334.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TEM
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer